FDA 510(k)

Access CEA

K-Number: K223921 · 2023-09-22

Decision Date2023-09-22

Product CodeDHX

Advisory CommitteeIM

DecisionSubstantially Equivalent

Device Summary

Access CEA is the device name listed in this FDA 510(k) record. The listed applicant is Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2023-09-22 under 510(k) number K223921. The device is classified under product code DHX. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Access CEA?

Access CEA is a medical device that received FDA 510(k) clearance on 2023-09-22. The listed applicant is Beckman Coulter, Inc.. The 510(k) number is K223921.

When did Access CEA receive FDA 510(k) clearance?

Access CEA received FDA 510(k) clearance on 2023-09-22, under 510(k) number K223921.

Who is the listed applicant for Access CEA?

The FDA 510(k) record lists Beckman Coulter, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Access CEA?

The FDA product code for Access CEA is DHX.

Other records listing Beckman Coulter, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252169Access BNP II K254059Access anti-HBc IgM K253687Access anti-HBc Total K251995Access anti-HAV IgM K250588Access Rubella IgG PMA P980041KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS

View all 84 devices →

Related Devices (Code: DHX)

K231517VITROS Immunodiagnostic Products CEA Reagent PackOrtho Clinical Diagnostics K200215ADVIA Centaur CEA AssaySiemens Healthcare Disgnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.